Lilly Commits Another $5.3bn To Tirzepatide Supply Expansion Effort

 
• By Joseph Haas
  
Manufacturing
Lilly is increasing manufacturing spending driven by tirzepatide demand • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business